Regulatory mechanisms in maintenance and modulation of transmembrane lipid asymmetry: Pathophysiological implications

Lupus

Volumn 5, Issue 5, 1996, Pages 480-487

  Bevers, E M ^a,b   Comfurius, P ^a   Zwaal, R F A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Antiphospholipid antibodies; Blood coagulation; Cell recognition; Phosphatidylserine; Scramblase; Translocase

Indexed keywords

AMINOPHOSPHOLIPID; MEMBRANE LIPID; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PHOSPHOPROTEIN;

CONFERENCE PAPER; LIPID COMPOSITION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0029852111     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500531     Document Type: Conference Paper

References (101)

1. Schroit AJ, Zwaal RFA. Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim Biophys Acta 1991; 1071:313-329.
2. Devaux PF, Zachowski A. Maintenance and consequences of membrane phospholipid asymmetry. Chem Phys Lipids 1994; 73:107-120.
3. Williamson P, Schlegel RA. Back and forth: the regulation and function of transbilayer phospholipid movement in eukaryotic cells. Mol Memb Biol 1994; 11:199-216.
4. Seigneuret M, Devaux PF. Asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: Relation to shape changes. Proc Natl Acad Sci USA 1984; 81:3751-3755.
5. Zachowski A et al. Outside-inside translocation of aminophospholipids in the human erythrocyte membrane is mediated by a specific enzyme. Biochem 1986; 25:2585-2590.
6. Beleznay Z et al. ATP-Dependent Aminophospholipid Translocation in Erythrocyte Vesicles - Stoichiometry of Transport. Biochemistry 1994; 32:3146-3152.
7. Martin OC, Pagano RE. Transbilayer movement of fluorescent analogs of phosphatidylserine and phosphatidylethanolamine at the plasma membrane of cultured cells. J Biol Chem 1987; 262:5890-5898.
8. Smeets EF, Comfurius P, Bevers EM, Zwaal RFA. Calcimn-induced transbilayer scrambling of fluorescent phospholipid analogs in platelets and erythrocytes. Biochim Biophys Acta 1994; 1195:281-286.
9. Hall PH and Huestis WH. Phosphatidylserine headgroup diastereomers translocate equivalently across human erythrocyte membranes. Biochim Biophys Acta 1994; 1190:243-247.
10. Connor J, Schroit AJ. Transbilayer movement of phosphatidylserine in erythrocytes. Inhibition of transport and preferential labeling of a 31 000 Dalton protein by sulfhydryl reactive reagents. Biochemistry 1988; 27:848-851.
11. Connor J, Pak CH, Zwaal RFA, Schroit AJ. Bidirectional transbilayer movement of phospholipid analogs in human red blood cells. J Biol Chem 1992; 267:19412-19417.
12. Bitbol M, Fellmann P, Zachowski A, Devaux PF. Ion regulation of phosphatidylserine and phosphatidylethanolamine outside-inside translocation in human erythrocytes. Biochim Biophys Acta 1987; 904:268-282.
13. Morrot G, Zachowski A, Devaux PF. Partial purification and chracterization of the human Mg2 + -ATPase: A candidate aminophospholipid translocase. FEBS Lett 1990; 266:29-32.
14. Auland ME, Roufogalis BD, Devaux PF, Zachowski A. Reconstitution of ATP-dependent aminophospholipid translocation in proteoliposomes. Proc Natl Acad Sci USA 1994; 91:10938-10942.
15. Zachowski A, Dolis D, Moreau C, Devaux PF. Reconstitution of an aminophospholipid translocase activity in proteoliposomes. Jacques Monod Conference on Lipid diversity in membranes and cellular functions, 1995 (Abstract).
16. Schroit AJ, Madsen J, Ruoho AE. Radioiodinated, photoaffinity-labeled phosphatidylcholine and phosphatidylserine Transfer properties and differential photoreactive reaction with human erythrocyte membrane proteins. Biochemistry 1987; 26:1812-1819.
17. Schroit AJ, Bloy C, Connor J, Cartron JP. Involvement of Rh Blood Group Polypeptides in the Maintenance of Aminophospholipid Asymmetry. Biochemistry 1990; 29:10303-10306.
18. Connor J, Schroit, AJ. Transbilayer movement of phosphatidylserine in non-human erythrocytes: Evidence that the aminophospholipid transporter is a ubiquitous membrane protein. Biochemistry 1989; 28:9680-9685.
19. Zachowski A, Henry JP, Devaux PF Control of transmembrane lipid asymmetry in chromaffin granules by an ATP-dependent protein. Nature 1989; 340:75-76.
20. Julien M, Tournier JF, Tocanne IF. Basic fibroblast growth factor modulates the aminophospholipid translocase activity present in the plasma membrane of bovine aortic endothelial cells. Eur J Biochem 1995; 230:287-297.
21. Hanada K, Pagano RE. A Chinese hamster ovary cell mutant defective in the non-endocytic uptake of fluorescent analogs of phosphatidylserine: isolation using a cytosol acidification protocol. J Cell Biol 1995; 128:793-804.
22. Bitbol M, Devaux PF. Measurement of outward translocation of phospholipids across human erythrocyte membrane. Proc Nat Acad Sci USA 1988; 85:6783-6787.
23. Connor J, Gillum K, Schroit AJ. Maintenance of lipid asymmetry in red blood cells and ghosts. Effect of divalent cations and serum albumin on the transbilayer distribution of phosphatidylserine. Biochim Biophys Acta 1990; 1025:82-86.
24. Henseleit U, Plasa G, Haest CWM. Effects of divalent cations on lipid flip-flop in the human erythrocyte membrane. Biochim Biophys Acta 1990; 1029:127-135.
25. Haest CWM, Deuticke B. Possible relationship between membrane proteins and phospholipid asymmetry in the human erythrocyte membrane. Biochim Biophys Acta 1976; 436:353-365.
26. Haest CWM, Plasa G, Kamp D, Deuticke B. Spectrin as a stabilizer of the phospholipid asymmetry in the human erythrocyte membrane. Biochim Biophys Acta 1978; 509:21-32.
27. Smit JJ et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993; 75:451-459.
28. Ruetz S, Gros P. Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell 1994; 77:1071-1081.
29. Higgins CF, Gottesman MM. Is the multidrug transporter a flippase?. Trends Biochem Sci 1992; 17:18-21.
30. Bevers EM et al. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface off platelets. Eur J Biochemistry 1982; 122:429-436.
31. Bevers EM, Comfurius P, Zwaal RFA. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983; 736:57-66.
32. Zwaal RFA, Comfurius P, Bevers EM. Mechanism and function of changes in membrane-phospholipid asymmetry in platelets and erythrocytes. Biochem Soc Trans 1993; 21:248-254.
33. Kuypers FA et al. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently-labeled annexin V. Blood 1996; 87:1179-1187.
34. Bevers EM et al. The complex of phosphatidylinositol 4,5-bisphosphate and calcium ions is not responsible for Ca(2 +)-induced loss of phospholipid asymmetry in the human erythrocyte: a study in Scott syndrome, a disorder of calcium-induced phospholipid scrambling. Blood 1995; 86:1983-1991.
35. Sulpice JC, Zachowski A, Devaux PF, Giraud F. Requirement for phosphatidylinositol 4,5-bisphosphate in the Ca(2 +)-induced phospholipid redistribution in the human erythrocyte membrane. J Biol Chem 1994; 269:6347-6354.
36. Bevers EM et al. Defective Ca(2 +)-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: a study of the red blood cells of Scott syndrome. Blood 1992; 79:380-388.
37. Williamson P et al. Phospholipid asymmetry in erythrocyte ghosts. J Cell Physiol 1985; 123:209-214.
38. Martin DW, Jesty J. Calcium stimulation of procoagulant activity in human erythrocytes. ATP dependence and the effects of modifiers of stimulation and recovery. J Biol Chem 1995; 270:10468-10474.
39. Williamson P et al. Ca2 + induces transbilayer redistribution of all major phospholipids in human erythrocytes. Biochemistry 1992; 31:6355-6360.
40. Williamson P et al. Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets. Biochemistry 1995; 34:10448-10455.
41. Bevers EM et al. Exposure of endogenous phosphatidylserine at the outer surface of stimulated platelets is reversed by restoration of aminophospholipid translocase activity. Biochemistry 1989; 28:2382-2387.
42. Comfurius P et al. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim Biophys Acta 1990; 1026:153-160.
43. Comfurius P et al. Reconstitution of phospholipid scramblase activity from human blood platelets. Biochemistry 1996; 35:7631-34.
44. Sims PJ et al. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989; 264:17049-17057.
45. Wiedmer T, Shattil SJ, Cunningham M, Sims PJ. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry 1990; 29:623-632.
46. Fox JEB, Austin CD, Reynolds C, Steffen PK. Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J Biol Chem 1991; 266:13289-13295.
47. Dachary-Prigent J et al. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl. Blood 1993; 81:2554-2565.
48. Dachary-Prigent J, Pasquet JM, Freyssinet JM, Nurden AT. Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2 +-ATPase inhibitors. Biochemistry 1995; 34:11625-11634.
49. Rosing J et al. Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder. Blood 1985; 65:1557-1561.
50. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance and regulation. Biochem 1991; 30:10363-10370.
51. Kalafatis M, Swords NA, Rand MD, Mann KG. Membrane-dependent reactions in blood coagulation: role of the vitamin K-dependent enzyme complexes. Biochim Biophys Acta 1994; 1227:113-129.
52. Mann KG et al. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 1990; 76:1-16.
53. Gilbert GE, Drinkwater D. Specific membrane binding of factor VIII is mediated by O-phospho-L-serine, a moiety of phosphatidylserine. Biochemistry 1993; 32:9577-9585.
54. Comfurius P et al. Assembly of the prothrombinase complex on lipid vesicles depends on the stereochemical configuration of the polar headgroup of phosphatidylserine. Biochemistry 1994; 33:10319-10324.
55. Smeets EF, Comfurius P, Bevers EM, Zwaal RFA. Contribution of different phospholipid classes to the prothrombin converting capacity of sonicated lipid vesicles. Thromb Res 1996; 81:419-426.
56. Esmon CT. The protein C anticoagulant pathway. Arterioscl Thromb 1992; 12:135-145.
57. Zwaal RFA et al. Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells; mechanism and physiological significance. Mol Cell Biochem 1989; 91:23-31.
58. Rosing J et al. The role of activated human platelets in prothrombin and factor X activation. Blood 1985; 65:319-332.
59. Weiss HJ. Scott syndrome, a disorder of platelet coagulant activity. Semin Hematol 1994; 31:312-319.
60. Miletich JP et al. Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorder. Blood 1979; 54:1015-1022.
61. Ahmad SS, Rawala-Sheikh R, Ashby B, Walsh PN. Platelet receptor-mediated factor X activation by factor IXa. High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott Syndrome. J Clin Invest 1989; 84:824-828.
62. Toti F et al. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications is an inherited disorder. Blood 1996; 87:1409-1475.
63. Kojima H et al. Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome J Clin Invest 1994; 94:2237-2244.
64. Connor J, Pak CH, Schroit AJ. Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age, and clearance by mononuclear cells. J Biol Chem 1994; 269:2399-2404.
65. Tait JF, Gibson, D. Measurement of membrane phospholip id asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding. J Lab Clin Med 1994; 123:741-748.
66. Franck PFH et al. Uncoupling of the membrane skeleton from the lipid bilayer: The cause of accelerated phospholipid flip-flop leading to enhanced procoagulant activity of sickled cells. J Clin Invest 1985; 75.183-190.
67. Blumenfeld N et al. Transmembrane mobility of phospholipids in sickle erythrocytes: effect of deoxygenation on diffusion and asymmetry. Blood 1991; 77:849-854.
68. Wilson MJ, Richter-Lowney K, Daleke DL. Hyperglycemia induces a loss of phospholipid asymmetry in human erythrocytes. Biochemistry 1993; 32:11302-11310.
69. Lupu C, Calb M, Ionescu M, Lupu F Enhanced prothrombin and intrinsic factor X activation on blood platelets from diabetic patients. Thrombosis Haemostasis 1993; 70:579-583.
70. Tracy PB, Eide LL, Mann KG. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations. J Biol Chem 1985; 260:2119-2124.
71. Tracy PB. Regulation of thrombin generation at cell surfaces. Semin Thromb Haemostas 1988; 14:227-233.
72. Robinson RA, Worfolk L, Tracy PB. Endotoxin enhances the expression of monocyte prothrombinase activity. Blood 1992; 79:406-416.
73. Satta N et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharides. J Immunol 1994; 153:3245-3255.
74. Hamilton KK, Hattori R, Esmon CT, Sims PJ. Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem 1990; 265:3809-3814.
75. VanDeMeer BW, Fugate RD, Sims PJ. Complement proteins C5b-9 induce transbilayer migration of membrane phospholipids. Biophys J 1989; 56:935-946.
76. Taylor FB et al. Infusion of phospholipid vesicles amplifies the local thrombotic response to IMF and anti-protein C into a consumptive response. Thromb Haemost 1996; 75:578-585.
77. Andoh K et al. Tissue factor activity in leukemia cells. Special reference to disseminated intravascular coagulation. Cancer 1987; 59::748-754.
78. Bauer KA et al. Tissue factor gene expression in acute myeloblastic leukemia. Thrombosis Research 1989; 56:425-430.
79. Falanga A, Gordon SG. Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue. Biochemistry 1985; 24:5558-5567.
80. VanDeWater L et al. Tumor cell generation of thrombin via functional prothrombinase assembly. Cancer Res 1985; 45:5521-5525.
81. Utsugi T et al. Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res 1991; 51:3062-3066.
82. Rao LV, Tait JF, Hoang AD. Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity. Thrombosis Research 1992; 67:517-31.
83. Dvorak HF et al. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res 1983; 43:4434-4442.
84. McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Advanc Immunol 1991; 49:193-280.
85. Roubey RA. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood 1994; 84:2854-2867.
86. Galli M et al. Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles. Br J Haematol 1993; 83:466-472.
87. Bevers EM et al. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemostasis 1991; 66:629-02.
88. Pierangeli SS et al. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb Haemost 1995; 74:1361-1367.
89. Schroit AJ, Madsen J, Tanaka Y. In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. J Biol Chem 1985; 260:5131-5138.
90. Pradhan D, Williamson P, Schlegel RA. Phosphatidylserine vesicles inhibit phagocytosis of erythrocytes with a symmetric distribution of phospholipids. Molecular Membrane Biology 1994; 11:181-188.
91. Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993; 14:131-136.
92. Fadok VA et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148:2207-2216.
93. Koopman G et al. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84:1415-1420.
94. Martin SJ et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995; 182:1545-1556.
95. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylsenne exposure, a phagocyte recognition signal on apoptotic T lymphocytes. J Exp Med 1995; 182:1597-1601.
96. Squier MK, Miller AC, Malkinson AM, Cohen JJ. Calpain activation in apoptosis. J Cell Physiol 1994; 159:229-237.
97. Bennett MR, Gibson DF, Schwartz SM, Tait JF. Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circulation Research 1995; 77:1136-1142.
98. Ottnad E et al. A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: Partial purification and role in recognition of oxidatively damaged cells. Proc Natl Acad Sci USA 1995; 92:1391-1395.
99. Sambrano GR, Steinberg D. Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: Role of membrane phosphatidylsenne. Proc Natl Acad Sci USA 1995; 92:1396-1400.
100. Chonn A, Semple SC, Cullis P. β2-Glycoprotein-I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of non-self particles J Biol Chem 1995; 270:25845-25849.
101. Fadok VA et al. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992; 149:4029-4035.